BioNTech
BNTX
284 hedge funds and large institutions have $4.56B invested in BioNTech in 2025 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 85 increasing their positions, 75 reducing their positions, and 35 closing their positions.
91% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 35
13% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 75
12% more funds holding
Funds holding: 254 → 284 (+30)
0.27% more ownership
Funds ownership: 21% → 21.27% (+0.27%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less call options, than puts
Call options by funds: $138M | Put options by funds: $142M
8% less capital invested
Capital invested by funds: $4.97B → $4.56B (-$415M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$117M |
| 2 |
D.E. Shaw & Co
New York
|
+$49.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.4M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$47.8M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$44.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$668M |
| 2 |
P
Pfizer
New York
|
-$164M |
| 3 |
Bank of New York Mellon
New York
|
-$45.8M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$36.9M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$35.2M |
BNTX Hedge Fund Activity: Q4 2025 in Review
284 of the 8,266 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q4 2025, worth a combined $4.56B — down 8.3% from $4.97B a quarter earlier.
Buyers outnumbered sellers: 67 funds opened new BNTX positions and 35 closed out — a net gain of 32 holders — while 85 added to existing stakes and 75 trimmed.
The largest buyer was Jane Street, adding an estimated $117M. The largest seller was Baillie Gifford & Co, cutting an estimated $668M.
- 284 institutional investors held BioNTech (BNTX) as of Q4 2025, up from 254 in Q3 2025.
- Funds reported $4.56B of BioNTech stock for Q4 2025, down 8.3% quarter-over-quarter.
- 67 funds opened new BioNTech positions in Q4 2025 and 35 closed out, a net change of +32 holders.
- The largest BioNTech buyer in Q4 2025 was Jane Street, an estimated $117M added.
- The largest BioNTech seller in Q4 2025 was Baillie Gifford & Co, an estimated $668M sold.
Based on aggregated 13F filings for Q4 2025.